Eksborg S - Search Results

1

Pharmacokinetics and Toxicity of Sodium Selenite in the Treatment of Patients with Carcinoma in a Phase I Clinical Trial: The SECAR Study.

Brodin O, Eksborg S, Wallenberg M, Asker-Hagelberg C, Larsen EH, Mohlkert D, Lenneby-Helleday C, Jacobsson H, Linder S, Misra S, Björnstedt M. Brodin O, et al. Among authors: eksborg s. Nutrients. 2015 Jun 19;7(6):4978-94. doi: 10.3390/nu7064978. Nutrients. 2015. PMID: 26102212 Free PMC article. Clinical Trial.

2

A novel oral insulin-like growth factor-1 receptor pathway modulator and its implications for patients with non-small cell lung carcinoma: A phase I clinical trial.

Ekman S, Harmenberg J, Frödin JE, Bergström S, Wassberg C, Eksborg S, Larsson O, Axelson M, Jerling M, Abrahmsen L, Hedlund Å, Alvfors C, Ståhl B, Bergqvist M. Ekman S, et al. Among authors: eksborg s. Acta Oncol. 2016;55(2):140-8. doi: 10.3109/0284186X.2015.1049290. Epub 2015 Jul 10. Acta Oncol. 2016. PMID: 26161618 Clinical Trial.

3

Epirubicin as a single agent therapy for the treatment of breast cancer--a pharmacokinetic and clinical study.

Eksborg S, Hardell L, Bengtsson NO, Sjödin M, Elfsson B. Eksborg S, et al. Med Oncol Tumor Pharmacother. 1992;9(2):75-80. doi: 10.1007/BF02989657. Med Oncol Tumor Pharmacother. 1992. PMID: 1341719

4

Electrochemical treatment of cancer. III: Plasma pharmacokinetics of adriamycin after intraneoplastic administration.

Eksborg S, Nordenström BE, Beving H. Eksborg S, et al. Am J Clin Oncol. 1990 Apr;13(2):164-6. doi: 10.1097/00000421-199004000-00015. Am J Clin Oncol. 1990. PMID: 2316483

5

Pharmacokinetics of anthracyclines.

Eksborg S. Eksborg S. Acta Oncol. 1989;28(6):873-6. doi: 10.3109/02841868909092323. Acta Oncol. 1989. PMID: 2611038

6

Oral melphalan pharmacokinetics--relation to dose in patients with multiple myeloma.

Ehrsson H, Eksborg S, Osterborg A, Mellstedt H, Lindfors A. Ehrsson H, et al. Among authors: eksborg s. Med Oncol Tumor Pharmacother. 1989;6(2):151-4. doi: 10.1007/BF02985238. Med Oncol Tumor Pharmacother. 1989. PMID: 2747308

7

Methotrexate plasma pharmacokinetics: importance of assay method.

Eksborg S, Albertioni F, Rask C, Beck O, Palm C, Schroeder H, Peterson C. Eksborg S, et al. Cancer Lett. 1996 Nov 29;108(2):163-9. doi: 10.1016/s0304-3835(96)04394-7. Cancer Lett. 1996. PMID: 8973590

8

Plasma pharmacokinetics of etoposide (VP-16) after i.v. administration to children.

Eksborg S, Söderhäll S, Frostvik-Stolt M, Lindberg A, Liliemark E. Eksborg S, et al. Anticancer Drugs. 2000 Apr;11(4):237-41. doi: 10.1097/00001813-200004000-00002. Anticancer Drugs. 2000. PMID: 10898537

9

Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: multi-institutional collaborative study.

Frost BM, Eksborg S, Björk O, Abrahamsson J, Behrendtz M, Castor A, Forestier E, Lönnerholm G. Frost BM, et al. Among authors: eksborg s. Med Pediatr Oncol. 2002 May;38(5):329-37. doi: 10.1002/mpo.10052. Med Pediatr Oncol. 2002. PMID: 11979457 Clinical Trial.

10

Effects on cyclo-oxygenase of low and high dose aspirin.

Beving H, Eksborg S, Nordlander R, Olsson P, Olsson U. Beving H, et al. Among authors: eksborg s. Thromb Res. 1990 Jul 15;59(2):227-35. doi: 10.1016/0049-3848(90)90126-w. Thromb Res. 1990. PMID: 2122535

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

247 results

Search Page